FindMyKOL
Clinical trialNCT00409617CompletedPhase 3Interventional

Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

SponsorAbbottEnrollment945Crohn's Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety of adalimumab for treatment of patients with moderate to severe Crohn's Disease (CD) and to measure the effects of treatment on patient general well-being, health-related quality of life (QoL), fistula healing, CD-related extra-intestinal manifestations, work performance, and overall activity.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

189 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Site Ref # / Investigator 3077

    Graz, Austria

  • Site Ref # / Investigator 2975

    Vienna, Austria

  • Site Ref # / Investigator 2976

    Vienna, Austria

  • Site Ref # / Investigator 2978

    Vienna, Austria

  • Site Ref # / Investigator 2977

    Wels, Austria

Belgium
  • Site Ref # / Investigator 3023

    Bonheiden, Belgium

  • Site Ref # / Investigator 3021

    Brussels, Belgium

  • Site Ref # / Investigator 3074

    Brussels, Belgium

  • Site Ref # / Investigator 3020

    Edegem, Belgium

  • Site Ref # / Investigator 3625

    Ghent, Belgium

  • Site Ref # / Investigator 3773

    Leuven, Belgium

  • Site Ref # / Investigator 3022

    Liège, Belgium

  • Site Ref # / Investigator 3047

    Roeselare, Belgium

Czechia
  • Site Ref # / Investigator 3893

    Brno, Czechia

  • Site Ref # / Investigator 4657

    Olomouc, Czechia

  • Site Ref # / Investigator 4659

    Prague, Czechia

  • Site Ref # / Investigator 4660

    Prague, Czechia

Denmark
  • Site Ref # / Investigator 3075

    Aalborg, Denmark

  • Site Ref # / Investigator 3037

    Aarhus C, Denmark

  • Site Ref # / Investigator 3088

    Elsinore, Denmark

  • Site Ref # / Investigator 3076

    Hvidovre, Denmark

  • Site Ref # / Investigator 3019

    Odense C, Denmark

Finland
  • Site Ref # / Investigator 3623

    Hyvinkää, Finland

France
  • Site Ref # / Investigator 3032

    Amiens, France

  • Site Ref # / Investigator 3012

    Besançon, France

  • Site Ref # / Investigator 2993

    Bordeaux, France

  • Site Ref # / Investigator 2983

    Béthune, France

  • Site Ref # / Investigator 2982

    Caen, France

  • Site Ref # / Investigator 3015

    Clichy, France

  • Site Ref # / Investigator 3011

    Colombes, France

  • Site Ref # / Investigator 3030

    Créteil, France

  • Site Ref # / Investigator 3033

    Créteil, France

  • Site Ref # / Investigator 3048

    Grenoble, France

  • Site Ref # / Investigator 3097

    Lille, France

  • Site Ref # / Investigator 3031

    Marseille, France

  • Site Ref # / Investigator 2985

    Montfermeil, France

  • Site Ref # / Investigator 2994

    Montpellier, France

  • Site Ref # / Investigator 3014

    Nantes, France

  • Site Ref # / Investigator 3029

    Nice, France

  • Site Ref # / Investigator 2995

    Paris, France

149 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2006
Primary completion
31 Jul 2008
Completion
31 Jul 2008
Last update posted
10 Oct 2011
Registered enrollment
945
Registry id
NCT00409617

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.